Internal Medicine · Indianapolis, IN
NPI
1720061732
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6620 Parkdale Pl
Indianapolis, IN, 46254
Phone (317) 415-7373
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
737 services
Medicare patients, 2024
249
Average age 72
Drug cost, 2024
$1.7M
14,647 prescriptions
Company payments, 2025
$72.36
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel M Overcash was code 99214 (office e&m - established), 312 times for 162 patients. In total Daniel M Overcash billed 737 services in 25 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 312 | 162 | $74.59 | $23K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 191 | 191 | $119.87 | $23K |
| 99215 Office E&M - Established | Office | 28 | 26 | $112.07 | $3,138 |
| G0008 Administration of influenza virus vaccine | Office | 20 | 20 | $24.50 | $490 |
| 99213 Office E&M - Established | Office | 20 | 18 | $39.75 | $795 |
| 90677 Vaccine Product | Office | 18 | 18 | $256.56 | $4,618 |
| G0009 Administration of pneumococcal vaccine | Office | 15 | 15 | $24.50 | $368 |
By year: 2022 $82K for 1,099 services; 2023 $110K for 1,214 services; 2024 $60K for 737 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel M Overcash prescribed most often to Medicare patients was Atorvastatin Calcium, with 870 prescriptions and refills. In total Daniel M Overcash wrote 14,647 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 870 | 2,390 | 230 | $6,511 |
| Amlodipine Besylate Generic | 576 | 1,592 | 152 | $3,074 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 442 | 448 | 68 | $15K |
| Omeprazole Generic | 372 | 803 | 78 | $4,402 |
| Metformin Hcl Generic | 331 | 846 | 78 | $2,120 |
| Levothyroxine Sodium Generic | 325 | 806 | 73 | $2,780 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 302 | 302 | 32 | $13K |
| Gabapentin Generic | 291 | 487 | 63 | $4,344 |
| Losartan Potassium Generic | 279 | 759 | 74 | $2,178 |
| Metoprolol Succinate Generic | 251 | 639 | 62 | $3,773 |
| Ozempic Semaglutide | 244 | 329 | 52 | $309K |
| Pantoprazole Sodium Generic | 234 | 507 | 55 | $4,412 |
| Tamsulosin Hcl Generic | 218 | 522 | 51 | $2,973 |
| Lisinopril Generic | 205 | 568 | 56 | $1,093 |
| Metformin Hcl Er Metformin Hcl | 190 | 439 | 46 | $1,408 |
Brand drugs: 1,871 claims; generic drugs: 12,596 claims; opioid claims: 1,065.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel M Overcash $72.36 ($72.36 in general payments such as food, travel and fees) from 4 companies. The largest payer was CooperSurgical, Inc. with $19.74.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.